Little Dog was founded 15 years ago with a simple but important belief: that great science deserves clear, strategic storytelling, no matter the size of the company.
From the beginning, the work has centered on partnership. We have been brought in when companies are forming, when platforms are still taking shape, and when the science is complex and the stakes are high. Our role is to help teams articulate what they are building, why it matters, and how it fits into a rapidly evolving scientific and commercial landscape.
Over the years, we have worked alongside founders and leadership teams as they move from early scientific vision to defined platforms, from private financing to public markets, from single programs to diversified pipelines. The work is never static. It evolves as the company evolves, shaped by new data, new questions, and new inflection points.
A consistent thread across 15 years is helping companies communicate around moments of transition. Financing events, clinical milestones, strategic partnerships, and acquisitions all require more than announcement language. They demand clarity and credibility. Much of our work has focused on aligning scientific truth with strategic narrative, ensuring that what is said externally resonates with investors, partners, media, and scientific peers alike.
We have spent significant time translating complex science into narratives that are accessible without being simplified, ambitious without being inflated. This includes platform storytelling across modalities such as cell and gene therapy, RNA-based approaches, targeted protein degradation, antibodies, diagnostics, and enabling technologies. In many cases, the challenge has been not to make the science louder, but to make it clearer.
Media engagement and executive visibility have been part of the work as a way to bring clarity and context to the people behind the science. Through interviews, profiles, and long-form coverage, we have helped leaders communicate not just what they are building, but why it matters, in ways that reflect how they think, lead, and show up for the patients and communities their work is meant to serve.
What I value most, looking back over 15 years, is having had the privilege to work with clients over long stretches of their journey. Many of our client relationships have stretched across years and across very different chapters of company growth, from early uncertainty to moments of real momentum. That longevity reflects trust, but it also reflects a shared way of working: showing up consistently, staying thoughtful when things are complex, and respecting both the science and the process it takes to move it forward.
Fifteen years in, Little Dog remains focused on the same core idea. The most important stories in life sciences are not told at the end of the journey, but along the way, at moments when clarity and communications can change outcomes. Our role has been, and continues to be, helping companies navigate those moments with precision, integrity, and purpose.